Oppenheimer Maintains Outperform on Hamilton Lane, Lowers Price Target to $171

Benzinga Newsdesk www.benzinga.com Negative 94.8%

Neg 94.8% Neu 0% Pos 0%

Oppenheimer analyst Chris Kotowski maintains Hamilton Lane (NASDAQ:HLNE) with a Outperform and lowers the price target from $230 to $171.